AI Governance in Skilled Nursing
A Practical Framework for Responsible AI Adoption, Oversight, and Readiness
in 2026
Leadership White Paper for Skilled Nursing and Long-Term Care
At a Glance
Artificial intelligence is no longer a future consideration for skilled nursing facilities. It is already embedded in many of the systems facilities use every day – from electronic health records and clinical risk models to documentation tools, staffing platforms, analytics dashboards, cybersecurity systems, and resident monitoring technologies. The challenge is that AI adoption has moved faster than most organizations’ governance structures. There is currently no single comprehensive federal “AI rule” written specifically for skilled nursing facilities. Instead, AI use intersects with an existing and rapidly evolving network of federal and state requirements involving privacy, security, discrimination, clinical decision support, medical devices, consumer protection, employment practices, resident rights, and healthcare quality. For SNF leaders, the practical question is therefore not: “Do we have an AI regulation we need to follow?” The better question is: “Where is AI being used in our organization, what decisions does it influence, and what governance should surround it?”
KNOW -> ASSESS -> GOVERN -> MONITOR -> IMPROVE Know where AI exists. Assess its potential impact. Establish appropriate governance. Monitor performance and outcomes. Improve controls as technology, regulation, and clinical practice evolve.
Executive Summary
Artificial intelligence has moved from buzzword to basic infrastructure across healthcare. Electronic health records, staffing systems, documentation platforms, predictive analytics, clinical decision-support tools, remote monitoring technologies, and administrative systems increasingly incorporate algorithms or AI capabilities into everyday workflows. Skilled nursing facilities may therefore be using AI even when leadership has never formally purchased an “AI product.” An EHR may calculate deterioration risk. A documentation platform may suggest language. A scheduling application may predict staffing needs. A pharmacy system may identify medication concerns. A monitoring platform may identify changes in resident behavior or physiology. A generative AI application may summarize clinical information. Each capability creates potential value – but also creates governance questions. Who validates the information? Can a clinician understand why the system generated a recommendation? Could the model perform differently across resident populations? What resident information is being transmitted to a vendor? Could staff unintentionally place protected health information into a public generative AI platform? What happens when an AI-generated recommendation is wrong? Who remains accountable for the final decision? Federal regulators are approaching these issues through multiple existing authorities rather than through one unified healthcare AI law. Depending on the technology and use case, organizations may need to consider HIPAA, federal nondiscrimination requirements, FDA oversight, health-information-technology rules, cybersecurity expectations, consumer-protection requirements, employment law, state privacy laws, and professional standards of care.
The absence of a single SNF-specific AI regulation should not be interpreted as the absence of regulatory exposure. The strongest strategy for skilled nursing organizations in 2026 is therefore proactive governance.
1. AI Is Already Hiding in Your SNF
Many skilled nursing leaders would say their organization is only beginning to explore artificial intelligence. Operationally, however, AI may already be present throughout the facility. Common examples include EHR modules that suggest documentation, calculate clinical risk scores, identify possible medication issues, prioritize residents for review, or detect changes in condition. Analytics platforms may predict hospitalization risk, identify quality trends, prioritize clinical interventions, or highlight residents whose data deviates from expected patterns. Workforce systems increasingly incorporate forecasting, automated scheduling, applicant screening, productivity analysis, or staffing recommendations. Clinical technologies may analyze vital signs, movement, falls, wounds, medication patterns, behavioral changes, or other resident information. Generative AI adds another dimension. Employees can now summarize information, draft communications, analyze data, or generate clinical text using tools that may exist entirely outside the organization’s approved technology environment. If protected health information or confidential organizational information is entered into an unapproved system, significant privacy and security concerns may arise.
You cannot govern AI you cannot see.
2. The Regulatory Landscape: There Is No Single SNF AI Rule
The regulatory environment surrounding healthcare AI is fragmented. At the federal level, multiple agencies and frameworks may apply depending on what the AI does, what information it processes, who uses it, and whether it influences care. The U.S. Department of Health and Human Services has continued developing policy and strategy around responsible AI use in healthcare. ASTP/ONC requirements addressing algorithmic transparency and decision-support interventions have increased expectations that certain health IT developers provide information about how predictive technologies function. The FDA continues to regulate certain AI-enabled technologies when they meet the definition of medical devices and has expanded guidance addressing software, lifecycle management, and modifications to AI-enabled medical devices. At the same time, the National Institute of Standards and Technology’s AI Risk Management Framework provides a widely recognized structure for identifying, assessing, managing, and monitoring AI risk. For skilled nursing organizations, these developments create an important distinction: Not every AI system is regulated in the same way. Governance must therefore follow the use case, not simply the label “AI.”
3. Start With Discovery: Build an AI Inventory
Before creating an AI policy, organizations should determine where AI is already operating. This requires more than asking the IT department which AI products have been purchased.
AI capabilities may exist within EHR systems, pharmacy platforms, workforce applications, revenue-cycle tools, remote monitoring technologies, clinical decision-support systems, security applications, analytics platforms, resident engagement tools, vendor portals, and ordinary productivity software. The inventory should identify the system, vendor, AI functionality, information used, intended purpose, users, output generated, decisions influenced, level of human review, and potential resident or workforce impact. Facilities should also look for “shadow AI.” Employees may independently use publicly available generative AI applications to summarize notes, rewrite emails, prepare care-plan language, create education materials, analyze spreadsheets, or answer clinical questions.
You cannot govern AI you cannot see.
4. Classify AI by Risk, Not by Novelty
Not every AI tool requires the same level of oversight. A system that helps rewrite an internal meeting agenda presents fundamentally different risks than a model that recommends which resident requires immediate clinical attention. Lower-risk applications may include administrative drafting, workflow assistance, scheduling support, or nonclinical summarization where outputs are reviewed before use. Moderate-risk applications may influence staffing, operational prioritization, resident communication, documentation, or financial processes. Higher-risk applications include technologies that influence diagnosis, treatment, medication decisions, clinical prioritization, hospitalization decisions, resident safety, employment decisions, or access to services.
AI risk should be measured by the consequence of being wrong.
5. Human Oversight Must Remain Meaningful
“Human in the loop” has become a common phrase in AI governance, but simply having a human click an approval button does not constitute meaningful oversight. Clinical staff must be able to question an AI recommendation. They must have access to the underlying clinical information needed to evaluate it. They should understand the important factors contributing to the recommendation when the technology permits that transparency. And they must retain authority to disagree. AI should support clinical judgment rather than quietly replace it. This distinction becomes especially important in skilled nursing, where residents frequently have multiple chronic conditions, polypharmacy, cognitive impairment, functional limitations, behavioral health needs, and rapidly changing clinical presentations. AI can recognize patterns. It cannot replace the full clinical context available to a knowledgeable caregiver.
6. AI Monitoring Belongs in QAPI
Healthcare organizations have traditionally treated technology implementation as an IT project. AI requires a different approach. Once an AI system influences resident care or operational decisions, monitoring its performance becomes a quality issue. That makes QAPI a natural governance structure.
Organizations can monitor whether AI-generated alerts are clinically meaningful, whether staff routinely override recommendations, whether false positives create alert fatigue, whether important conditions are missed, whether outcomes improve, and whether the system creates unintended workflow burden. An AI system that technically performs as designed but creates additional documentation, duplicate review processes, or unnecessary alerts may still be a poor clinical tool. The question should not simply be: “Is the algorithm accurate?” It should also be: “Is this making care safer, clearer, and easier to deliver?”
7. Bias and Fairness Require Attention
AI systems learn from data, and healthcare data reflects the strengths and weaknesses of the systems that created it. Incomplete documentation, unequal access to healthcare, demographic differences, historical treatment patterns, socioeconomic factors, and other variables can influence model performance. Organizations using AI for clinical prioritization, staffing, employment, resource allocation, or resident services should consider whether outcomes vary meaningfully across populations. The goal is to identify whether technology is creating or amplifying inappropriate disparities. Human oversight remains essential, particularly when an algorithm influences decisions with meaningful consequences for residents or employees.
8. Vendor Due Diligence Must Change
Traditional healthcare technology procurement often focuses on price, functionality, implementation, integration, cybersecurity, and support. AI requires additional questions. Organizations should understand what information the model uses, where data is processed, whether organizational data is used to train models, whether subcontractors or third-party AI providers receive data, how frequently models change, how performance is validated, what limitations are known, and how customers are notified when significant changes occur. Contracts should also address privacy, security, data ownership, breach responsibilities, model updates, regulatory compliance, and termination. One particularly important question is: What happens to our data after the AI has processed it? If the vendor cannot clearly answer that question, the organization has not completed its due diligence.
9. Transparency Builds Trust
Healthcare workers are more likely to trust technology when they understand what it is doing. A risk score without context can easily become another number on a screen. A risk score accompanied by understandable contributing factors becomes clinically useful information. For example, telling a nurse that a resident has a “high risk score” provides limited guidance. Showing that the score is associated with a recent medication change, increasing respiratory rate, reduced oral intake, and a recent hospitalization gives the nurse information that can support clinical reasoning.
Transparency does not mean every clinician must understand the mathematics behind a machine-learning model. It means users should understand enough about the system’s purpose, inputs, limitations, and outputs to use it responsibly.
Trust should not be demanded from clinicians. It should be earned through good design.
10. AI Governance Is Also Workflow Governance
One of the most overlooked risks of healthcare AI is workflow burden. Technology can be clinically accurate and still fail because it arrives at the wrong time, appears on the wrong screen, generates too many alerts, duplicates existing work, or requires staff to leave their normal workflow to find the information. AI governance should therefore evaluate workflow impact alongside technical performance. Before implementing a new system, leaders should ask: Where will this information appear? Who is expected to respond? How quickly? What existing step does this replace? What happens when the recommendation is ignored? Does it reduce work or add another layer of review? The success of healthcare AI should not be measured by the number of algorithms deployed. It should be measured by whether the technology improves decisions without unnecessarily competing for clinicians’ attention.
11. A Practical 90-Day AI Readiness Plan
Days 1-30: KNOW. Identify AI-enabled technologies already operating across the organization. Create an AI
inventory. Identify unapproved generative AI use. Review existing privacy, cybersecurity, technology, clinical decision-support, HR, and vendor policies. Determine who currently approves new AI-enabled technologies.
Days 31-60: ASSESS AND GOVERN. Classify AI systems according to potential clinical, privacy, workforce,
financial, and operational risk. Identify high-risk applications requiring stronger oversight. Create an interdisciplinary AI governance group. Establish rules for acceptable and prohibited AI use. Define human-review expectations. Establish vendor due-diligence requirements. Determine which AI activities should be incorporated into QAPI.
Days 61-90: MONITOR AND IMPROVE. Begin monitoring higher-risk systems. Track overrides, false
positives, false negatives, staff feedback, workflow burden, resident outcomes, and unintended consequences where appropriate. Provide staff education on approved and prohibited AI use. Review vendor changes and emerging regulatory requirements. Schedule recurring governance reviews.
From Adoption to Accountability
Artificial intelligence has enormous potential in skilled nursing. It can identify patterns that humans may not immediately recognize. It can reduce administrative work. It can help clinicians prioritize information. It can strengthen monitoring. It can surface changes in resident condition earlier. And when thoughtfully designed, it can return something increasingly scarce in healthcare: attention. But technology does not become trustworthy simply because it is intelligent. Trust comes from transparency. It comes from validation. It comes from appropriate human oversight. It comes from understanding where
information goes, how decisions are influenced, and what happens when the technology is wrong. For skilled nursing leaders, the goal should not be to slow innovation. The goal should be to create the conditions in which innovation can be used responsibly.
KNOW -> ASSESS -> GOVERN -> MONITOR -> IMPROVE The organizations best prepared for the next generation of healthcare technology will not necessarily be those that adopt AI first. They will be the organizations that understand how to govern it.
Appendix A: SNF AI Inventory & Risk Assessment
Recommended classifications: Low Risk – administrative support with limited consequences if output is incorrect. Moderate Risk – technology influencing workflow, documentation, communication, staffing, or operational decisions. High Risk – technology influencing clinical decisions, resident safety, diagnosis, treatment, hospitalization, medication management, employment, or access to services.
Appendix B: AI Vendor Due-Diligence Checklist
Appendix C: 90-Day AI Readiness Roadmap
Month One – KNOW: Inventory AI-enabled technologies; identify shadow AI; identify organizational owners;
review existing policies; identify technologies handling PHI or influencing resident care.
Month Two – ASSESS & GOVERN: Risk-classify AI systems; establish an interdisciplinary governance
structure; create acceptable-use standards; define human-oversight requirements; strengthen vendor-review processes; identify high-risk systems requiring formal monitoring.
Month Three – MONITOR & IMPROVE: Begin performance monitoring; integrate appropriate AI measures
into QAPI; educate employees; review workflow impact; create a regulatory monitoring process; establish recurring AI governance meetings.
Appendix D: AI Governance Meeting Agenda
- New AI Technologies – Review newly proposed or discovered AI-enabled technologies.
- Current AI Inventory – Review changes to existing applications, vendors, integrations, or use cases.
- High-Risk AI Review – Evaluate performance, clinical impact, overrides, incidents, and identified concerns.
- Privacy and Security – Review PHI handling, vendor changes, cybersecurity events, and unauthorized AI use.
- Quality and Safety – Review relevant QAPI indicators, resident outcomes, false positives, false negatives, and unintended consequences.
- Workforce and Workflow – Review staff feedback, alert burden, documentation burden, and workflow impact.
- Bias and Fairness – Review whether significant differences in outcomes have been identified across populations.
- Regulatory Updates – Review applicable federal and state developments.
- Vendor Changes – Review model updates, functionality changes, validation information, and contractual issues.
- Action Items – Assign owners, deadlines, escalation requirements, and follow-up dates.
Primary Regulatory and Governance References
U.S. Department of Health and Human Services (HHS). Artificial Intelligence Strategy. Provides the department’s framework and strategic direction for responsible AI use across healthcare and human services. Assistant Secretary for Technology Policy / Office of the National Coordinator for Health Information Technology (ASTP/ONC). Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (HTI-1) Final Rule. U.S. Food and Drug Administration (FDA). Digital Health Policy and Guidance, including guidance addressing clinical decision-support software, software as a medical device, and AI-enabled medical technologies. U.S. Food and Drug Administration (FDA). Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations. U.S. Food and Drug Administration (FDA). Predetermined Change Control Plan Guidance for Artificial Intelligence-Enabled Device Software Functions. National Institute of Standards and Technology (NIST). Artificial Intelligence Risk Management Framework (AI RMF 1.0) and Generative Artificial Intelligence Profile. U.S. Department of Health and Human Services, Office for Civil Rights (OCR). HIPAA Privacy, Security, and Breach Notification Rules.
Leadership Takeaway
Skilled nursing organizations do not need to wait for a regulation titled “Artificial Intelligence in Nursing Homes.” The obligation to protect resident information, prevent discrimination, maintain appropriate clinical oversight, ensure quality of care, manage vendors, protect systems, and exercise reasonable professional judgment already exists. AI changes the technology. It does not eliminate the responsibility.
The question for 2026 is no longer whether skilled nursing will use AI. The question is whether skilled nursing will govern it as thoughtfully as it adopts it.
